NO20071706L - Koadministrering av Tigecycline og Digoxin. - Google Patents

Koadministrering av Tigecycline og Digoxin.

Info

Publication number: NO20071706L
Authority: NO; Norway
Prior art keywords: tigecycline; digoxin; administration; administered; human
Prior art date: 2004-10-28

Application number

NO20071706A

Other languages

English (en)

Norwegian (no)

Inventor

Donald G Raible

Gopal Muralidharan

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-28

Filing date

2007-03-30

Publication date

2007-05-24

2007-03-30 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-05-24 Publication of NO20071706L publication Critical patent/NO20071706L/no

Links

LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 title abstract 2
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 title abstract 2
229960005156 digoxin Drugs 0.000 title abstract 2
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 title abstract 2
FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 title abstract 2
229960004089 tigecycline Drugs 0.000 title abstract 2
238000011260 co-administration Methods 0.000 title 1
208000035143 Bacterial infection Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

NO20071706A 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin. NO20071706L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62285904P	2004-10-28	2004-10-28
PCT/US2005/038410 WO2006060084A2 (en)	2004-10-28	2005-10-24	Coadministration of tigecycline and digoxin

Publications (1)

Publication Number	Publication Date
NO20071706L true NO20071706L (no)	2007-05-24

Family

ID=36127476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071706A NO20071706L (no)	2004-10-28	2007-03-30	Koadministrering av Tigecycline og Digoxin.

Country Status (18)

Country	Link
US (1)	US20060094668A1 (de)
EP (1)	EP1804807B1 (de)
JP (1)	JP2008518911A (de)
KR (1)	KR20070069182A (de)
CN (1)	CN101039679A (de)
AT (1)	ATE415973T1 (de)
AU (1)	AU2005310306A1 (de)
BR (1)	BRPI0517406A (de)
CA (1)	CA2582089A1 (de)
CR (1)	CR9073A (de)
DE (1)	DE602005011468D1 (de)
EC (1)	ECSP077423A (de)
IL (1)	IL182681A0 (de)
MX (1)	MX2007005163A (de)
NO (1)	NO20071706L (de)
RU (1)	RU2007112409A (de)
WO (1)	WO2006060084A2 (de)
ZA (1)	ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102512429A (zh)	2005-03-14	2012-06-27	惠氏公司	替加环素组合物及制备方法
AR055336A1 (es) *	2005-06-16	2007-08-22	Wyeth Corp	Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) *	2008-06-17	2009-12-23	Elias Bouras	A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) *	2008-08-06	2010-02-11	Wyeth	Tigecycline formulations
MY199695A (en)	2017-01-27	2023-11-18	Neurocrine Biosciences Inc	Methods for the administration of certain vmat2 inhibitors
DK3684333T3 (da)	2017-09-21	2025-05-12	Neurocrine Biosciences Inc	Valbenazin-formulering med høj dosis og sammensætninger, fremgangsmåder og kits relateret hertil
US20200230127A1 (en)	2017-10-10	2020-07-23	Neurocrine Biosciences, Inc.	Methods for the Administration of Certain VMAT2 Inhibitors

2005
- 2005-10-24 BR BRPI0517406-6A patent/BRPI0517406A/pt not_active IP Right Cessation
- 2005-10-24 EP EP05851251A patent/EP1804807B1/de not_active Expired - Lifetime
- 2005-10-24 DE DE602005011468T patent/DE602005011468D1/de not_active Expired - Fee Related
- 2005-10-24 CN CNA2005800350112A patent/CN101039679A/zh active Pending
- 2005-10-24 KR KR1020077009607A patent/KR20070069182A/ko not_active Withdrawn
- 2005-10-24 AU AU2005310306A patent/AU2005310306A1/en not_active Abandoned
- 2005-10-24 RU RU2007112409/14A patent/RU2007112409A/ru not_active Application Discontinuation
- 2005-10-24 MX MX2007005163A patent/MX2007005163A/es not_active Application Discontinuation
- 2005-10-24 CA CA002582089A patent/CA2582089A1/en not_active Abandoned
- 2005-10-24 JP JP2007539052A patent/JP2008518911A/ja active Pending
- 2005-10-24 AT AT05851251T patent/ATE415973T1/de not_active IP Right Cessation
- 2005-10-24 WO PCT/US2005/038410 patent/WO2006060084A2/en not_active Ceased
- 2005-10-28 US US11/261,259 patent/US20060094668A1/en not_active Abandoned
2007
- 2007-03-30 NO NO20071706A patent/NO20071706L/no not_active Application Discontinuation
- 2007-04-19 IL IL182681A patent/IL182681A0/en unknown
- 2007-04-20 CR CR9073A patent/CR9073A/es not_active Application Discontinuation
- 2007-04-26 ZA ZA200703441A patent/ZA200703441B/xx unknown
- 2007-04-27 EC EC2007007423A patent/ECSP077423A/es unknown

Also Published As

Publication number	Publication date
WO2006060084A3 (en)	2006-07-20
BRPI0517406A (pt)	2008-10-07
EP1804807A2 (de)	2007-07-11
ATE415973T1 (de)	2008-12-15
CR9073A (es)	2007-08-28
ECSP077423A (es)	2007-05-30
RU2007112409A (ru)	2008-12-10
US20060094668A1 (en)	2006-05-04
IL182681A0 (en)	2007-09-20
AU2005310306A1 (en)	2006-06-08
JP2008518911A (ja)	2008-06-05
EP1804807B1 (de)	2008-12-03
CA2582089A1 (en)	2006-06-08
DE602005011468D1 (de)	2009-01-15
KR20070069182A (ko)	2007-07-02
CN101039679A (zh)	2007-09-19
MX2007005163A (es)	2007-06-26
WO2006060084A2 (en)	2006-06-08
ZA200703441B (en)	2008-09-25

Similar Documents

Publication	Publication Date	Title
NO20070988L (no)	2007-05-04	Vaksine for forebygging og behandling av HIV-infeksjon
NO20064547L (no)	2006-10-06	Fremgangsmater for behandling av HIV infeksjon
DK2109602T3 (da)	2014-05-19	Tetracyclinderivater til behandling af bakterielle, virale og parasitiske infektioner
DK1773361T3 (da)	2009-11-16	Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme og/eller infektioner og til forbedring af en intestinale funktionalitet
TN2010000137A1 (en)	2011-09-26	Spiropyrrolidines and their use against hcv and hiv infection
NO20071706L (no)	2007-05-24	Koadministrering av Tigecycline og Digoxin.
LT1951272T (lt)	2016-10-10	Lactobacillus panaudojimas virusinių infekcijų gydymui
NO20081842L (no)	2008-07-08	Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
NO20074943L (no)	2007-10-01	Roflumilast for behandlingen av diabetes mellitus
EP2192901A4 (de)	2010-10-13	Chemikalien, zusammensetzungen und verfahren zur behandlung und prävention von orthopoxvirus-infektionen und damit assoziierten krankheiten
DK1638589T3 (da)	2014-06-30	Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
NO20052362D0 (no)	2005-05-12	Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
EA201171186A1 (ru)	2012-05-30	Сокристалл этравирина и никотинамида
NO20072285L (no)	2007-06-13	S-mirtazapin for behandling av hetetokter
MX2009011930A (es)	2009-11-18	Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
DK1919466T3 (da)	2012-07-02	Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
DK1848415T3 (da)	2013-07-08	Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
ZA200802934B (en)	2009-09-30	Use of lactobacillus for treatment of virus infections
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
DK1861080T3 (da)	2010-09-06	Idebenon til behandling af muskeldystrofier
NO20080495L (no)	2008-03-10	PEG-IFN-alfa og ribavirin for HBV-behandling
ATE433459T1 (de)	2009-06-15	Desoxo-nonadepsipeptide
GB0414886D0 (en)	2004-08-04	Treatment of bacterial infections
ATE455789T1 (de)	2010-02-15	Substituierte nonadepsipeptide
UA110918C2 (uk)	2016-03-10	Інгібітори протеїнфосфатази-1 та їх застосування

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application